logo
Select company
Select metric
-164.44%Net Margin
VS
Market
11
Sector
35
Industry
61
History
68
$ 18Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Net Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - Net % Historical data
DateNet Income Common StockNet MarginRevenues
6/30/2025$ -154.97M-164.44%$ 94.24M
3/31/2025$ -138.43M-150.68%$ 91.87M
12/31/2024$ -126.87M-140.35%$ 90.4M
9/30/2024$ -115.38M-129.11%$ 89.36M
6/30/2024$ -113.58M-133.61%$ 85.01M
3/31/2024$ -104.32M-123.74%$ 84.3M
12/31/2023$ -102.24M-123.61%$ 82.71M
9/30/2023$ -105.1M-136%$ 77.28M
6/30/2023$ -109.05M-150.37%$ 72.52M
3/31/2023$ -111.6M-164.16%$ 67.98M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) Net % stands at -3572.42%.
  • Over the past 5 years, UROGEN PHARMA LTD's average Net % has been -414.88%.
  • The median Net % for UROGEN PHARMA LTD during this period was -167.51%
  • UROGEN PHARMA LTD reached its highest Net % over the past 5 years at -123.61%.
  • The lowest Net % recorded by UROGEN PHARMA LTD in the same timeframe -3572.42%

UROGEN PHARMA LTD's Net % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net % Benchmarks
CompanyNet %
NRIX : NURIX THERAPEUTICS INC -292.5%SNDX : SYNDAX PHARMACEUTICALS INC -428.48%GYRE : GYRE THERAPEUTICS INC 4.08%CRMD : CORMEDIX INC 42.11%NAGE : NIAGEN BIOSCIENCE INC 15.24%ZYME : ZYMEWORKS INC -59.96%PHAT : PHATHOM PHARMACEUTICALS INC -289.51%TBPH : THERAVANCE BIOPHARMA INC 16.88%WVE : WAVE LIFE SCIENCES LTD -138.24%KURA : KURA ONCOLOGY INC -236.76%

Definition of Net Margin

[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Net Inc. Cmn. / Revenues
(=) Net %
Net % for UROGEN PHARMA LTD is calculated as follows: Net Inc. Cmn. [ $ -136.93M ] / Revenues [ $ 3.83M ]
(=) Net % [ -3572.42% ]

URGN - Net Margin, Last 5 years

-3572.42%

Minimum

Sep 30, 2020

-123.61%

Maximum

Dec 31, 2023

-414.88%

Average

-167.51%

Median

Net % Benchmark Analysis

The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
filtered constituents3.2K
min-64.23%
max69.74%
average4.77%
median5.24%
std19.84%